ArticleBMC cancer2023

Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy.

Ya-Dong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.